TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 5,935,000 Value ($000) $8,440 Avg Close — Range —
Q3 2025
Shares 1,622,000 Value ($000) $1,829 Avg Close — Range —